We are live on
!
Find out more
FLC
Fifth Lane Capital Portfolio holdings
AUM
$1.63M
Turnover
95%
1-Year Est. Return
7.3%
This Fund
S&P 500
This Quarter
Est. Return
+5.14%
1 Year Est. Return
+7.3%
3 Year Est. Return
+80.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$82.3M
AUM Growth
-$49.6M
(-38%)
Cap. Flow
-$1.36M
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
68.24%
Holding
153
New
35
Increased
13
Reduced
6
Closed
95
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.1
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cantor Equity Partners V
CEPV
|
+$7.67M |
| 2 |
OS
OneStream Inc
OS
|
+$7.57M |
| 3 |
Hologic
HOLX
|
+$4.66M |
| 4 |
Renatus Tactical Acquisition Corp I
RTAC
|
+$3.73M |
| 5 |
Electronic Arts
EA
|
+$3.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.8M |
| 2 |
Cantor Equity Partners IV
CEPF
|
+$4.82M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$4.4M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$3.69M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$2.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 21.59% |
| 3 | Technology | 19.82% |
| 4 | Miscellaneous | 12.75% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Renatus Tactical Acquisition Corp I
RTAC
$325M
| $11.2M | 13.61% |
1,089,815
+352,511
| +48% | +$3.73M |
2025 Q3
2 quarters
|
|
|
OS
2
DELISTED
OneStream Inc
OS
| $7.74M | 9.4% |
+322,630
| New | +$7.57M |
2026 Q1
0 quarters
|
|
|
3
Cantor Equity Partners V
CEPV
$324M
| $7.65M | 9.29% |
+753,500
| New | +$7.67M |
2026 Q1
0 quarters
|
|
|
4
DELISTED
Hologic
HOLX
| $7.15M | 8.68% |
94,528
+62,028
| +191% | +$4.66M |
2025 Q3
2 quarters
|
|
|
CEPT
5
DELISTED
Cantor Equity Partners II
CEPT
| $5.73M | 6.96% |
526,494
+273,016
| +108% | +$3.13M |
2025 Q2
3 quarters
|
|
6
New America Acquisition I Corp Units
NWAX.U
| $4.46M | 5.42% |
430,000
+4,500
| +1% | +$47K |
2025 Q4
1 quarter
|
|
|
7
DELISTED
Electronic Arts
EA
| $3.57M | 4.33% |
+17,500
| New | +$3.53M |
2026 Q1
0 quarters
|
|
8
DELISTED
Arcellx
ACLX
| $3.56M | 4.33% |
+31,044
| New | +$2.74M |
2026 Q1
0 quarters
|
|
9
FutureCrest Acquisition Corp
FCRS
$367M
| $2.8M | 3.41% |
278,704
+36,004
| +15% | +$364K |
2025 Q4
1 quarter
|
|
10
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$5.7B
| $2.32M | 2.81% |
+40,000
| New | +$2.51M |
2026 Q1
0 quarters
|
|
11
New America Acquisition I Corp
NWAX
$500M
| $2M | 2.43% |
+200,000
| New | +$2.02M |
2026 Q1
0 quarters
|
|
12
FutureCrest Acquisition Corp Units
FCRS.U
| $1.94M | 2.35% |
+190,200
| New | +$1.95M |
2026 Q1
0 quarters
|
|
13
UnitedHealth
UNH
$360B
| $1.89M | 2.3% |
7,000
+1,300
| +23% | +$387K |
2025 Q2
3 quarters
|
|
14
Abivax
ABVX
$7.74B
| $1.77M | 2.14% |
15,858
+12,408
| +360% | +$1.47M |
2025 Q4
1 quarter
|
|
15
Core Scientific
CORZ
$4.47B
| $1.49M | 1.81% |
99,752
+56,752
| +132% | +$968K |
2025 Q4
1 quarter
|
|
16
NVIDIA
NVDA
$5.25T
| $1.31M | 1.59% |
7,500
+2,000
| +36% | +$367K |
2024 Q4
5 quarters
|
|
17
C1 Fund Inc
CFND
$17.7M
| $1.27M | 1.54% |
+329,760
| New | +$1.42M |
2026 Q1
0 quarters
|
|
18
Vistance Networks Inc
VISN
$1.37B
| $1.17M | 1.43% |
64,552
+54,552
| +546% | +$995K |
2025 Q3
2 quarters
|
|
19
Nektar Therapeutics
NKTR
$1.24B
| $863K | 1.05% |
+12,000
| New | +$683K |
2026 Q1
0 quarters
|
|
20
Advanced Micro Devices
AMD
$886B
| $814K | 0.99% |
4,000
+1,000
| +33% | +$214K |
2025 Q4
1 quarter
|
|
21
Oracle
ORCL
$393B
| $736K | 0.89% |
5,000
-1,000
| -17% | -$163K |
2025 Q4
1 quarter
|
|
22
TSMC
TSM
$2.16T
| $676K | 0.82% |
2,000
-1,000
| -33% | -$344K |
2025 Q2
3 quarters
|
|
23
USA Today Co
TDAY
$1.04B
| $572K | 0.69% |
+81,123
| New | +$497K |
2026 Q1
0 quarters
|
|
24
Aimco
AIV
$245M
| $570K | 0.69% |
+140,000
| New | +$733K |
2026 Q1
0 quarters
|
|
25
Tesla
TSLA
$1.41T
| $558K | 0.68% |
1,500
-1,100
| -42% | -$453K |
2025 Q2
3 quarters
|
|
Similar funds
CA
HGCK
EW
AI
CC
1IC
MP
DF
Fifth Lane Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Fifth Lane Capital held 153 positions worth $82.3M, down 38% from $132M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Fifth Lane Capital's Q1 2026 filing shows 35 new, 13 increased, 6 reduced and 95 closed positions. Its largest new stake was Cantor Equity Partners V: 753,500 shares worth $7.65M. The largest sale was iShares Core S&P 500 ETF, an estimated $18.8M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.
- Fifth Lane Capital's largest Q1 2026 buy was Cantor Equity Partners V: 753,500 shares worth $7.65M.
- Fifth Lane Capital added most to Hologic in Q1 2026, an estimated $4.66M increase.
- Fifth Lane Capital's biggest Q1 2026 reduction was Burford Capital, cutting an estimated $475K.
- Fifth Lane Capital fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $18.8M.
- Fifth Lane Capital's ten largest holdings make up 68% of its $82.3M portfolio in Q1 2026.
- Fifth Lane Capital opened 35 new positions and closed 95 in Q1 2026.
- Fifth Lane Capital's portfolio value fell 38% quarter-over-quarter to $82.3M.
Based on Fifth Lane Capital's 13F filing for Q1 2026, filed 15 May 2026.